PwC Legal has advised IBSA Group on the acquisition of its long-term distributor on the Czech market, IBI spol. s r.o. IBI was advised by Solo Practitioners Violeta Jirackova and Rostislav Zak.
IBSA is a multinational pharmaceutical company, headquartered in Lugano, Switzerland, that was founded in 1945 by a group of Swiss biologists. As a result of the transaction, IBSA becomes the sole shareholder of IBI, and the company's name will be changed to IBSA Pharma.
“The acquisition is part of the IBSA Group’s project to enlarge its commercial operations through its subsidiaries,” stated Arturo Licenziati, President of IBSA. IBI has distributed pharmaceutical products manufactured by IBSA on the Czech market for more than 24 years.
PwC Legal’s team included Attorneys Daniel Pikal, Vendelin Balog, and Andrea Lancovova.